Gufic Biosciences Share Price

₹ 422.25

-₹17.60 (-4%)
1D
Last updated 18 Nov, 2026, 15:51 IST
NSE: GUFICBIO
|
Pharmaceuticals

Gufic Biosciences Share Price Today

As of 19 Nov 2026, Gufic Biosciences share price is ₹422.25. The stock opened at ₹441.95, compared to its previous close of ₹439.85. During today's trading session, Gufic Biosciences share price moved in the range of ₹421.00 to ₹441.95, with an average price of ₹431.48 for the day. Looking at its last 52-week, the stock has touched a low of ₹268.00 and a high of ₹493.95. On the performance front, Gufic Biosciences share price has increased by 52.38% over the last six months and is up 28.19% on a year-on-year basis.

Share price over the last 1 day fell from 436.05 to 422.00, ranging between 421.00 and 436.80.

₹421.00
4.00% down today
₹441.95
1D LOW
1D HIGH

Gufic Biosciences Stock Insights

Latest Earning
Op Profit TrendUp by 4.69% QoQ
Latest Earning
Net Profit TrendUp by 5.20% QoQ
Latest Earning
Revenue TrendUp by 10.76% QoQ
Stock Performance
OutperformingBeat Nifty by 45.04 % in last 6 month
Shareholding Pattern
DIIDII increased stake by 46.21%
Shareholding Pattern
FIIFII decreased stake by 3.65%
Gufic Biosciences stock performance
Open₹441.95
High₹441.95
Low₹421.00
Prev. close₹439.85
Gufic Biosciences trading activity
Volume1,51,573
Average traded price₹428.01
Last traded time03:51:16 18 Nov
Last traded quantity1

Circuit
L
H
₹351.90
₹527.80
52-week
L
H
₹268.00
₹493.95
Mkt Cap Cr
4,396.39

P/E
54.87

P/B
6.19

ROA
5.52%
ROE
11.29%

ROCE
12.34%

Quick Ratio
0.92

EV/EBITDA
27.27

Based on fundamentals, this stock's

Performance: 5 out of 5, Excellent
Performance
Excellent
Gufic BioScience outperforming all market indices
Valuation: 1 out of 5, Overvalued
Valuation
Overvalued
Gufic BioScience appears overvalued compared to its peers
Earnings: 4 out of 5, Good
Earnings
Good
Gufic BioScience revenue, operating profit and net profit are growing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,47,943.8440.845.039.61%13.79%18.65%2.3123.45
Divis Laboratories2,93,873.7287.7416.415.31%18.69%23.83%3.558.71
Torrent Pharmaceuticals1,78,390.6284.659.674.7%11.42%11.37%0.7534.13
Laurus Labs1,26,433.0694.8920.8611.58%22.11%20.91%0.6850.63
Zydus Lifesciences1,19,969.7927.894.317.63%15.1%14.86%0.9115.93
Dr. Reddy's Laboratories1,15,852.1741.982.994.79%7.21%8.58%1.3519.41
Cipla1,12,619.6039.163.166.6%8.18%10.8%2.521.27
Mankind Pharma1,07,612.7047.546.127.82%12.76%14.68%0.7426.3
Aurobindo Pharma1,03,145.1225.872.626.46%10.13%12.76%1.1512.45
Lupin90,201.0517.113.7213.08%21.65%24.54%1.4210.13

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

Gufic Biosciences Company Background

ISIN
INE742B01025
Sector Market Cap
₹ 4,396.39 Cr

Gufic Biosciences Limited is an India-based company, which is engaged in the manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals and related services. The Company operates in the pharmaceutical segment. It has pharmaceutical products under categories, such as Criti Care, including Doxific, Micafung, Rabol and Tigefic-Plus; Criticare Life, including Ticofic-200 and Gufivan-500; Ferticare, including Puregraf 75IU 3D, Cetrocare 0.25mg 3D and Follicare 150IU 3D; Spark, including Aznee Duo, Eclin, Flabone, Vipro M and Zad G; Herbal, including Bocomo-Forte, Sallaki-Liniment, Zulcer Cap and Smashit tablet, and Aesthaderm, including Prosil, Moiseta Face Wash and Revanox Serum. Its personal care products include StretchNil, Shapers-Natural Feel, Shaper-DryFeel and RollOn. Its products under active pharmaceutical ingredient (API)/bulk drugs include Micafungin, Anidulafungin, Sulconazole and Everolimus. Its Gufic Stridden includes Irvical and Eve.

Gufic Biosciences Financial Highlights

  • Revenue: Gufic Biosciences reported revenue of ₹946.67 crore in FY26 vs ₹823.44 crore in FY25. It showed an increase of 14.97% on a yearly basis.
  • Operating Profit: Gufic Biosciences reported an operating profit of ₹86.55 crore in FY26 vs ₹94.14 crore in FY25. It showed a decrease of 8.06% on a year-on-year basis.
  • Net Profit: Gufic Biosciences reported a net profit of ₹64.21 crore in FY26 vs ₹69.65 crore in FY25. It showed a decrease of 7.81% on a yearly basis.

Gufic Biosciences Quarterly Result Highlights

  • Gufic Biosciences reported revenue of ₹289.39 crore in Sep 2026, compared with ₹261.28 crore in Jun 2026, representing an increase of 10.76% on a quarter-on-quarter (QoQ) basis.
  • Gufic Biosciences reported an operating profit of ₹31.45 crore in Sep 2026, compared with ₹30.04 crore in Jun 2026, representing an increase of 4.69% on a quarter-on-quarter (QoQ) basis.
  • Gufic Biosciences reported a profit of ₹23.47 crore in Sep 2026, compared with ₹22.31 crore in Jun 2026, reflecting an increase of 5.20% on a QoQ basis.
  • The earnings per share (EPS) of Gufic Biosciences stood at ₹6.40 during Sep 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters
72.50%
FII
0.45%
Other DII
0.35%
Retail and other
23.67%
Mutual funds
3.03%
Foreign Institutional Investor (FII)
FII shareholding by period
Dec 20250.44%
Mar 20260.42%
Jun 20260.46%
Sep 20260.45%

Gufic Biosciences Investment Returns

1 day
-4.00%

1 week
-9.65%

1 month
+4.39%

1 year
+28.19%

3 years
+42.08%

5 years
+125.32%

Gufic Biosciences Share Price History

Gufic Biosciences share price history by day, showing open and close prices and the percentage change
Day
Open / Close
Change %
18 Nov 26
₹441.95 / ₹422.25
-4.00%
17 Nov 26
₹438.00 / ₹439.85
-0.35%
16 Nov 26
₹455.00 / ₹441.40
-6.69%
13 Nov 26
₹487.00 / ₹473.05
-2.86%
Show more

Gufic Biosciences Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024
Revenue₹944.01₹819.81₹806.67
Other Income₹2.66₹3.63₹2.18
Total Revenue₹946.66₹823.43₹808.84
Total Expenses₹860.12₹729.29₹693.17
Profit Before Tax₹86.55₹94.14₹115.67
Tax₹22.34₹24.49₹29.54
Profit After Tax₹64.21₹69.65₹86.14
EPS - Basic₹6.40₹6.95₹8.74
EPS - Diluted₹6.40₹6.95₹8.74

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024
Profit before tax₹64.21₹69.65₹86.14
Income before WC changes₹151.81₹137.94₹149.82
Change in Assets-₹131.09-₹9.02-₹170.27
Change in Liabilities₹36.26₹16.46₹40.04
Change in WC-₹94.83₹7.44-₹130.23
Cash flow from Operations₹45.14₹122.57-₹7.46
Cash flow from Investing-₹30.96-₹70.78-₹102.39
Cash flow from Financing₹32.29-₹37.20₹82.38
Total Cash Flow₹46.46₹14.59-₹27.47
Cash (Start of the year)₹15.72₹1.14₹28.60
Cash (End of the year)₹62.19₹15.72₹1.14

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024
Non-Current Assets₹540.26₹544.84₹492.06
Current Assets₹802.12₹624.52₹600.48
Total Assets₹1,342.37₹1,169.36₹1,092.54
Current Liabilities₹517.85₹387.56₹372.05
Net Current Asset₹284.27₹236.97₹228.43
Non-Current Liabilities₹159.54₹180.73₹187.93
Equity Capital₹664.99₹601.08₹532.56
Total Equity & Liabilities₹1,342.37₹1,169.36₹1,092.54

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹940.48₹819.81₹806.67₹690.62
Other Income₹2.58₹3.62₹2.18₹2.57
Total Revenue₹943.06₹823.42₹808.84₹693.19
Total Expenses₹857.57₹728.99₹693.17₹586.47
Profit Before Tax₹85.49₹94.43₹115.67₹106.72
Tax₹22.34₹24.49₹29.54₹27.02
Profit After Tax₹63.15₹69.93₹86.14₹79.70
EPS - Basic₹6.30₹6.97₹8.74₹8.22
EPS - Diluted₹6.30₹6.97₹8.74₹8.22

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹63.15₹69.93₹86.14₹79.70
Income before WC changes₹150.74₹138.22₹149.82₹136.36
Change in Assets-₹131.13-₹9.08-₹170.27-₹123.21
Change in Liabilities₹36.42₹16.44₹40.04-₹12.05
Change in WC-₹94.71₹7.37-₹130.23-₹135.25
Cash flow from Operations₹44.19₹122.78-₹7.46-₹26.59
Cash flow from Investing-₹30.96-₹71.79-₹102.40-₹190.73
Cash flow from Financing₹32.19-₹37.20₹82.38₹234.31
Total Cash Flow₹45.42₹13.78-₹27.48₹16.99
Cash (Start of the year)₹14.91₹1.13₹28.60₹11.61
Cash (End of the year)₹60.32₹14.91₹1.13₹28.60

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹541.33₹545.85₹492.07₹397.05
Current Assets₹800.26₹623.78₹600.47₹464.11
Total Assets₹1,341.59₹1,169.63₹1,092.54₹861.16
Current Liabilities₹517.87₹387.53₹372.05₹288.21
Net Current Asset₹282.39₹236.24₹228.42₹175.90
Non-Current Liabilities₹159.54₹180.73₹187.93₹225.14
Equity Capital₹664.18₹601.36₹532.56₹347.81
Total Equity & Liabilities₹1,341.59₹1,169.63₹1,092.54₹861.16
* All values are in INR Crore
Gufic Biosciences market depth
Bid quantityBid priceAsk priceAsk quantity
10422.2500
0000
0000
0000
0000
Total bid quantity10
Total ask quantity0
Gufic Biosciences technical summary
Bearish indicators1
Neutral indicators5
Bullish indicators2
OverallSlightly Bullish
by SEBI experts

Expert Pick

EXPPICK
Stop-loss
Stop-loss is locked. Sign in to view.
Entry price
Entry price is locked. Sign in to view.
Target
Target is locked. Sign in to view.
Indicator
Value
Verdict

RSI (14)
51.93
Neutral

ATR (14)
23.24
Neutral

STOCH(9,6)
47.63
Neutral

STOCH RSI (14)
9.46
Bullish

ADX(9)
33
Bearish

UO(9)
57.24
Neutral

ROC(12)
6.36
Bullish

WillR(14)
-52.37
Neutral
Period
Simple value
Exponential vaue

5D
461.73
452.22

10D
451.3
448.66

20D
430.27
438.72

50D
426.72
426.07

100D
414.31
407.21
Volume trend — traded volume by day
18 Nov1L
17 Nov0L
16 Nov4L
13 Nov2L
12 Nov2L
Average2L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks

Gufic Biosciences
Pharmaceuticals
Add Stock
Add Another

Mutual Funds Invested in Gufic Biosciences

Fund name
AUM
Bank of India Business Cycle Fund
0.87%

SBI Healthcare Opportunities Fund
0.69%

Bank of India Small Cap Fund
0.53%

Gufic Biosciences Returns Calculator

Ex-date: 28 Aug 2026

Gufic Biosciences Share Price FAQs












Please be aware that Gufic Biosciences stock prices are subject to continuous fluctuations due to various factors.